Their research is no paid for by the US gov't. Basic research is heavily subsidized, but basic research doesn't get you a drug and basic research is the cheapest part of the entire process. They are still shoving billions of dollars into bringing drugs to market, again, often not successfully.
And no, drug innovation is not highly subsidized by the gov't. Just look at budgets. NIH budget is $38B, of which a fraction is actually spent on research leading to new drugs. PhRMA (just the largest drug companies) spent $71B in 2017.[1] And that ignores the billions spent by VCs to fund start-ups, another $13B in the first 10 months of 2017.[2]
Adding it up, private spending on drug R&D is probably 5-10x that of what the gov't spends.
[1]https://www.biopharmadive.com/news/phrma-research-developmen... [2]http://www.pharmatimes.com/magazine/2018/december_2018/a_rec...
(Commentor works MedTech adjacent)